| Code | 44663 | ||||||||||
| MA number | EU/1/07/400/013 | ||||||||||
| Product Form: | sol inj 1x0,3 ml/250 µg (napl.inj.striek.skl.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Roche Registration GmbH, Germany | ||||||||||
| Therapeutic Class: | 12 - ANTIANAEMICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Subcutaneous and intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application |
| MA issued: | 20.07.2007 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
DHCP Mircera.PDF
|
| Safety feature | Yes |
| Data update: | 26.10.2023 |
